Clinuvel Pharmaceuticals Limited

CLVLF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0$36$31$21
Dep. & Amort.$0$1$1$1
Deferred Tax$0$0-$9$6
Stock-Based Comp.$0$0$9$6
Change in WC$0-$5-$3$6
Other Non-Cash$41$5$9$0
Operating Cash Flow$41$37$37$40
Investing Activities
PP&E Inv.-$0-$6-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$47-$23$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$48-$29-$1-$0
Financing Activities
Debt Repay.$0-$0-$0-$0
Stock Issued$0$4$0$0
Stock Repurch.-$0-$5$0$0
Dividends Paid-$3-$2-$2-$1
Other Fin. Act.-$0$0$0$0
Financing Cash Flow-$3-$4-$2-$2
Forex Effect$2-$1$2$1
Net Chg. in Cash-$7$3$35$39
Supplemental Information
Beg. Cash$35$32$122$83
End Cash$28$35$157$122
Free Cash Flow$41$31$36$39